Phase II Randomized Study of Pemetrexed With Sorafenib Versus Pemetrexed Alone as Second-Line Therapy in Patients With Advanced Non-Small Cell Lung Cancer.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Pemetrexed; Sorafenib
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 21 Mar 2017 Biomarkers information updated
- 18 Jun 2012 Actual end date (Jul 2010) added as reported by ClinicalTrials.gov.
- 18 Jun 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.